KRAS and colorectal carcinoma: As shown in Fig. 3, the pooled HR for the association between KRAS codon 13 gene mutations and OS in CRC patients was 1.37 (95% CI: 1.03–1.81, P = .03), with moderate heterogeneity between studies (P = .002, I2 = 67.0%).